Parecoxib (Compound)

Synonyms:Parecoxib, 198470-84-7, SC-69124, Xapit, SC 69124, Valus-P, Vorth-P, Rayzon, CHEBI:73038, N-((p-(5-methyl-3-phenyl-4-isoxazolyl)phenyl)sulfonyl)propionamide, N-[4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)phenyl]sulfonylpropanamide, 9TUW81Y3CE, N-[4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonyl]propanamide, Propanamide, N-((4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl)sulfonyl)-, Parocoxib, Propanamide, N-[[4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]-, N-{[4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)phenyl]sulfonyl}propanamide, parecoxibum, Parecoxib [USAN:INN:BAN], Valdecoxib Impurity J, PARECOXIB [INN], PARECOXIB [MI], Parecoxib (USAN/INN), PARECOXIB [USAN], UNII-9TUW81Y3CE, PARECOXIB [WHO-DD], SCHEMBL9529, PARECOXIB [EMA EPAR], GTPL2895, CHEMBL1206690, DTXSID1044229, HMS3741C09, HMS3885L14, AMY42103, BCP07254, EX-A1993, BDBM50506744, MFCD25976408, s4656, AKOS025401810, CCG-268299, CS-1959, DB08439, SC69124, NCGC00181773-03, NCGC00181773-05, NCGC00378576-02, Parecoxib 100 microg/mL in Acetonitrile, AC-25842, AS-72353, HY-17474, FT-0697932, Parecoxib, VETRANAL(TM), analytical standard, D03716, A854884, EN300-20600171, Q347941, J-523329, BRD-K13800121-236-01-7, Z2588040125, N-[4-(5-Methyl-3-phenyl-oxazol-4-yl)phenyl]sulfonylpropanamde, N-((4-(5-methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)propionamide, n-[[4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]-propanamide, n-[[4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]propanamide, N-{[4-(5-methyl-3-phenylisoxazol-4-yl)phenyl]sulfonyl}propanamide, N-[[4-(5-methyl-3-phenyl-4-isoxazolyl) phenyl] sulfonyl] propanamide, N-?[[4-?(5-?Methyl-?3-?phenyl-?4-?isoxazolyl)?phenyl]?sulfonyl]?propanamide, PXB

Pubchem:PUBCHEM:119828

Id:e6b18186-1799-5db0-b0ff-261467138a83

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Parecoxib's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Parecoxib.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Parecoxib.

Results found

Linked to

	Label	Description
	BRD-K13800121-001-01-5 Substance (Entity type)	A Substance
	parecoxib (c7705ff8-2ae2-4254-9bed-c1dc576f3bf5) Collection (Entity type)	Metadatata for parecoxib
	DCSTRUCT ID 02063 Collection (Entity type)	DrugPage Collection: (DrugCentralID:02063; PubChem_CID:119828, FILE=drugcentral_drug_02063.json)
	Parecoxib in similarity relationship with Clopidogrel Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Parecoxib positively regulates MAP3K5 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Parecoxib negatively regulates HMG20B Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Parecoxib negatively regulates PELI1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Parecoxib positively regulates TFF1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Parecoxib negatively regulates IFI6 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Parecoxib positively regulates BEX1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS